Metro Inc. closed 4.3% below its 52-week high of C$94.86, which the company reached on December 9th.

Cannot destructure property 'translate' of 'n' as it is null.

Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...

Tesla, IBM and Meta Platforms helped lead most U.S. stocks higher after a rush of profit reports from some of the country’s ...

Thursday's coverage included more tech earnings, focus on Trump's latest on potential tariffs and more analysis around Monday ...